MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
12.00
-0.92 (-7.12%)
Sep 5, 2025, 12:43 PM - Market open
MBX Biosciences Employees
MBX Biosciences had 43 employees as of December 31, 2024. The number of employees increased by 16 or 59.26% compared to the previous year.
Employees
43
Change (1Y)
16
Growth (1Y)
59.26%
Revenue / Employee
n/a
Profits / Employee
-$1,791,140
Market Cap
403.13M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 43 | 16 | 59.26% |
| Dec 31, 2023 | 27 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MBX News
- 1 day ago - MBX Biosciences Doses First Participant in Phase 1 Trial of MBX 4291 for the Treatment of Obesity - GlobeNewsWire
- 21 days ago - Microbix Biosystems Inc. (MBXBF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - MBX Biosciences Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 2 months ago - MBX Biosciences Appoints Andreas Moraitis, M.D., as Senior Vice President of Clinical Development - GlobeNewsWire
- 2 months ago - MBX Biosciences Announces IND Submission of MBX 4291, its Long-acting GLP1/GIP Receptor Co-agonist Prodrug for the Treatment of Obesity - GlobeNewsWire
- 3 months ago - MBX Biosciences to Present at the American Diabetes Association 85th Scientific Sessions - GlobeNewsWire
- 3 months ago - MBX Biosciences: Consider Peptide Developer With GLP Drugs As A Speculative Buy - Seeking Alpha
- 3 months ago - MBX Biosciences to Participate in June Investor Conferences - GlobeNewsWire